TAKEDA PHARMACEUTIC-SP ADR
TAKNYSE🏆 #264 by market capEarnings Oct 29US Equity
$17.43▼ $0.05 (−0.31%)
Live1h▼ 0.1%
24h▼ 0.3%
7d▲ 4.2%
14d▼ 1.9%
30d▲ 5.7%
1y▲ 19.0%
🏦Market Cap
$55.45B
Mid Cap
📈Revenue Growth (YoY)
+4.3%
Slowing
📊Gross Margin
62.1%
High
💵FCF Margin
15.2%
Healthy
⚖️P/S Ratio
1.9x
Cheap
Otter Score
64
Fair
Earnings
Q3 · 2026Reported 2026-07-30Earnings Per Share
Actual
0.23
Expected
0.17
beat
+33.20%
YoY −56.70%
Revenue
Actual
$7.66B
Expected
$7.13B
beat
+7.40%
YoY +4.20%
Consensus estimates
Recent quarters
Q3 2026
0.23
beat
Q2 2026
-0.05
miss
Q1 2026
0.21
miss
Q4 2025
-0.02
miss